VCI Global (Nasdaq: VCIG) cuts Alumni Capital shares to 19,990

Rhea-AI Filing Summary

VCI Global Ltd (VCIG) filed a prospectus supplement amending an earlier convertible note prospectus supplement to change the number of ordinary shares issuable to Alumni Capital LP under an August 13, 2025 Securities Purchase Agreement. The registered amount is now 19,990 ordinary shares, reduced from 55,556 ordinary shares, issuable upon conversion of convertible notes and exercise of warrants issued under that agreement.

The share figures reflect a 1-for-60 reverse stock split effective February 27, 2026 and a 1-for-15 reverse stock split effective August 24, 2026. The company states that all shares covered by this supplement have been sold and issued. VCIG’s ordinary shares trade on Nasdaq under the symbol VCIG, and the last reported sale price on August 21, 2026 was $0.2129 per share. VCI Global is classified as an emerging growth company and uses certain reduced reporting requirements.

Key Figures

Ordinary shares registered in supplement: 19,990 ordinary shares Prior ordinary shares amount: 55,556 ordinary shares Reverse stock split ratio: 1-for-60 +2 more

5 metrics

Ordinary shares registered in supplement 19,990 ordinary shares Shares issuable to Alumni Capital upon note conversion and warrant exercise under the amended supplement

Prior ordinary shares amount 55,556 ordinary shares Original number of shares issuable to Alumni Capital before the reduction in this supplement

Reverse stock split ratio 1-for-60 Reverse stock split of ordinary shares effective February 27, 2026

Reverse stock split ratio 1-for-15 Reverse stock split of ordinary shares effective August 24, 2026

Last reported sale price $0.2129 per share Nasdaq Capital Market closing price for ordinary shares on August 21, 2026

Key Terms

Prospectus Supplement, Securities Purchase Agreement, reverse stock split, underwriter, +1 more

5 terms

Prospectus Supplement regulatory

"This prospectus supplement (the “Prospectus Supplement”) amends and supplements"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

Securities Purchase Agreement financial

"pursuant to the Securities Purchase Agreement, dated August 13, 2025, by and between"

A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.

reverse stock split financial

"gives effect to (i) the 1-for-60 reverse stock split of the Company's Ordinary"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

underwriter regulatory

"Alumni Capital is an underwriter within the meaning of Section 2(a)(11)"

An underwriter is a financial firm that evaluates, guarantees and helps sell a new security offering—such as a stock or bond—by buying the issue from the issuer and reselling it to investors or organizing the sale. Think of them as a bridge or safety net: they take on the risk, set the price, handle marketing and paperwork, and their work determines how much money a company can raise and how smoothly the offering reaches the market.

emerging growth company regulatory

"We are an “emerging growth company,” as that term is defined under the federal"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Offering Details

shelf

Offering

Offering Type shelf

FAQ

What change does VCI Global Ltd (VCIG) make in this 424B5 prospectus supplement?

VCI Global Ltd reduces the number of ordinary shares covered for issuance to Alumni Capital LP from 55,556 to 19,990 ordinary shares, tied to the conversion of convertible notes and exercise of warrants under an August 13, 2025 Securities Purchase Agreement.

How many VCI Global Ltd (VCIG) shares are covered by the updated prospectus supplement?

The updated prospectus supplement covers 19,990 ordinary shares of VCI Global Ltd, reflecting a reduction from 55,556 shares in the earlier convertible note prospectus supplement and giving effect to two subsequent reverse stock splits.

Have the shares covered by this VCI Global Ltd (VCIG) prospectus supplement already been issued?

Yes. VCI Global Ltd states that all 19,990 ordinary shares covered by this prospectus supplement have been sold and issued as of the date of the supplement.

What reverse stock splits does VCI Global Ltd (VCIG) reference in this filing?

VCI Global Ltd references a 1-for-60 reverse stock split of its ordinary shares effective February 27, 2026, and a 1-for-15 reverse stock split effective August 24, 2026. The 19,990-share figure gives effect to both reverse splits.

What was the recent trading price of VCI Global Ltd (VCIG) ordinary shares cited in the supplement?

The supplement notes that on August 21, 2026, the last reported sale price of VCI Global Ltd ordinary shares on the Nasdaq Capital Market under symbol VCIG was $0.2129 per share.

What is Alumni Capital LP’s role in relation to VCI Global Ltd (VCIG) in this prospectus?

Alumni Capital LP is the investor receiving shares upon conversion of notes and exercise of warrants under the Securities Purchase Agreement and is identified as an underwriter within the meaning of Section 2(a)(11) of the Securities Act.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 06:01 AM Accepted by SEC EDGAR 08/24/2026 - 05:43 PM Learn about SEC filing dates

Filed Pursuant to Rule 424(b)(5)

Registration Statement No. 333-279521

Prospectus Supplement

(To Prospectus dated May 28, 2024)

 

19,990

Ordinary Shares

This prospectus supplement (the “Prospectus Supplement”) amends and supplements the prospectus supplement dated November 20, 2025 (the “Convertible Note Prospectus Supplement”) relating to the issuance of ordinary shares of VCI Global Ltd (“we,” “us,” “our,” or the “Company”), no par value per share (the “Shares”), to Alumni Capital LP (“Alumni Capital”) pursuant to the Securities Purchase Agreement, dated August 13, 2025, by and between us and Alumni (“Securities Purchase Agreement”).

We are filing this Prospectus Supplement to amend the Convertible Note Prospectus Supplement to decrease the amount of Shares issuable to Alumni Capital under the Convertible Note Prospectus Supplement from 55,556 ordinary shares to 19,990 ordinary shares upon conversion of convertible notes and the exercise of warrants issued pursuant to the Securities Purchase Agreement.

Alumni Capital is an underwriter within the meaning of Section 2(a)(11) of the U.S. Securities Act of 1933, as amended (the “Securities Act”). All the Shares covered by this Prospectus Supplement have been sold and issued as of the date of this Prospectus Supplement.

The number of Ordinary Shares referenced in this Prospectus Supplement gives effect to (i) the 1-for-60 reverse stock split of the Company's Ordinary Shares effected on February 27, 2026 and (ii) the 1-for-15 reverse stock split of the Company's Ordinary Shares effected on August 24, 2026.

You should read this prospectus supplement, the base prospectus, and any additional prospectus supplement or amendment carefully before you invest in our securities.

Our ordinary shares are listed on the Nasdaq Capital Market (“Nasdaq”) under the symbols “VCIG.” On August 21, 2026, the last reported sale price of our ordinary shares on Nasdaq was $0.2129 per share.

Investing in our securities involves a high degree of risk. See “Risk Factors” section beginning on page S-8 of the Convertible Note Prospectus Supplement.

We are an “emerging growth company,” as that term is defined under the federal securities laws and, as such, we have elected to comply with certain reduced public company reporting requirements and may elect to do so in future filings.

Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is August 24, 2026.